Literature DB >> 15020071

Nociceptin/orphanin FQ modulates human T cell function in vitro.

Paula S Waits1, Wendy M Purcell, Allison J Fulford, Julie D McLeod.   

Abstract

Although nociceptin/orphanin FQ (N/OFQ) and its receptor (ORL-1) are widely distributed throughout the immune system, its role has yet to be elucidated. This study shows that N/OFQ (10(-14)-10(-12) M) modulates T cell activation by up-regulating activation marker expression, e.g. CD28, leading to enhanced proliferation and modulation of TNFalpha secretion. However, on re-stimulated T cells N/OFQ causes inhibition of proliferation, which could be linked with N/OFQ up-regulating CTLA-4 expression. We have also shown that some of these effects are partly prostaglandin-dependent and that N/OFQ induces prostaglandin synthesis. This report suggests that N/OFQ could exert a key modulatory role in human T cell functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020071     DOI: 10.1016/j.jneuroim.2003.12.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses.

Authors:  A Anderson; C L Martens; R Hendrix; L L Stempora; W P Miller; K Hamby; M Russell; E Strobert; B R Blazar; T C Pearson; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2008-09-17       Impact factor: 8.086

2.  [Expression und function of the ORL-1 receptor on human leukocytes].

Authors:  C Krüger; L Köthe; A Struppert; C Pietruck; A Simm; S Grond
Journal:  Schmerz       Date:  2006-11       Impact factor: 1.107

3.  Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.

Authors:  Benito Anton; Phillipe Leff; Joseph J Meissler; Juan C Calva; Rodolfo Acevedo; Alberto Salazar; Maura Matus; Anabel Flores; Martin Martinez; Martin W Adler; John P Gaughan; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-02       Impact factor: 4.147

4.  Orphanin FQ/nociceptin activates nuclear factor kappa B.

Authors:  Courtney L Donica; Vanessa I Ramirez; Hibah O Awwad; Nurulain T Zaveri; Lawrence Toll; Kelly M Standifer
Journal:  J Neuroimmune Pharmacol       Date:  2011-05-06       Impact factor: 4.147

5.  The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis.

Authors:  Dickson Carvalho; Fabricia Petronilho; Francieli Vuolo; Roberta Albino Machado; Larissa Constantino; Remo Guerrini; Girolamo Calo; Elaine Cristina Gavioli; Emílio Luiz Streck; Felipe Dal-Pizzol
Journal:  Intensive Care Med       Date:  2008-10-10       Impact factor: 17.440

Review 6.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

7.  Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2007-09-15       Impact factor: 4.147

8.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

Review 9.  The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation.

Authors:  Elyse M Mallimo; Alexander W Kusnecov
Journal:  Front Cell Neurosci       Date:  2013-10-08       Impact factor: 5.505

10.  Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.

Authors:  J D Leggett; K L Dawe; D S Jessop; A J Fulford
Journal:  J Neuroendocrinol       Date:  2009-09-01       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.